Advisornet Financial’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,000
Closed -$6.3K 2308
2025
Q2
$6.3K Hold
1,000
﹤0.01% 1613
2025
Q1
$6.41K Sell
1,000
-1,000
-50% -$8.27K ﹤0.01% 1548
2024
Q4
$16.1K Buy
+2,000
New +$19.3K ﹤0.01% 1200
2022
Q1
Sell
-17
Closed -$2K 2129
2021
Q4
$2K Buy
+17
New +$2.92K ﹤0.01% 1834
2021
Q2
Sell
-20
Closed -$4K 1841
2021
Q1
$4K Buy
+20
New +$3.98K ﹤0.01% 1556
2020
Q2
Sell
-686
Closed -$9K 1874
2020
Q1
$9K Buy
+686
New +$5.8K ﹤0.01% 1295

Other funds holding NVAX

Advisornet Financial's NVAX Position: Q3 2025 in Review

Advisornet Financial sold out of Novavax (NVAX) in Q3 2025, closing a stake of 1,000 shares — an estimated $6.3K sold.

Advisornet Financial first reported a position in NVAX in Q1 2020 and held it in 6 quarters. The position peaked at $16.1K in Q4 2024. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Advisornet Financial reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Advisornet Financial sold 1,000 Novavax shares in Q3 2025, an estimated $6.3K.
  • Advisornet Financial first reported a position in Novavax in Q1 2020 and held it in 6 quarters.
  • Advisornet Financial's Novavax position peaked at $16.1K in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Advisornet Financial's 13F filing for Q3 2025, filed 9 Oct 2025.